Skip to main content
Clinical Trials/NCT01498250
NCT01498250
Completed
Not Applicable

Microarray Analysis of microRNA Expression in Basal Cell Carcinoma

Ruhr University of Bochum1 site in 1 country7 target enrollmentNovember 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Basal Cell Carcinoma
Sponsor
Ruhr University of Bochum
Enrollment
7
Locations
1
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Perturbations in microRNA (miRNA) expression profiles has been reported for a variety of cancers. This study will be an exploratory analysis of miRNA expression in basal cell carcinoma by miRNA expression profiling using microarrays.

Detailed Description

Perturbations in the expression profiles of microRNAs (miRNAs) have been reported for a variety of different cancers. Basal cell carcinoma (BCC) of the skin has not been systematically evaluated regarding differentially expressed miRNAs. Patients with BCC are included in the study to perform an exploratory analysis by miRNA expression profiling using microarrays. Expression levels of miRNA candidates will be validated by TaqMan real-time quantitative polymerase chain reaction (RT-PCR).

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
December 2011
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Ruhr University of Bochum
Responsible Party
Principal Investigator
Principal Investigator

Michael Sand

Principal Investigator

Ruhr University of Bochum

Eligibility Criteria

Inclusion Criteria

  • Basal Cell Carcinoma

Exclusion Criteria

  • Other Skin Cancer than Basal Cell Carcinoma

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials